SILVERMAN, E. (2012). PBM Consolidation: Better Pricing or Just Less Competition?: The growth of specialty pharmaceuticals, including biologics, is forcing payers and employers to look at cost-saving strategies for managing those drugs. How will they do it if only one large PBM rules the specialty pharmacy network? BioCommunications LLC.
Citação norma ChicagoSILVERMAN, ED. PBM Consolidation: Better Pricing or Just Less Competition?: The Growth of Specialty Pharmaceuticals, Including Biologics, Is Forcing Payers and Employers to Look At Cost-saving Strategies for Managing Those Drugs. How Will They Do It If Only One Large PBM Rules the Specialty Pharmacy Network? BioCommunications LLC, 2012.
Citação norma MLASILVERMAN, ED. PBM Consolidation: Better Pricing or Just Less Competition?: The Growth of Specialty Pharmaceuticals, Including Biologics, Is Forcing Payers and Employers to Look At Cost-saving Strategies for Managing Those Drugs. How Will They Do It If Only One Large PBM Rules the Specialty Pharmacy Network? BioCommunications LLC, 2012.